pharma

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part One

Now more than ever, pharmaceutical companies’ relationships with physician thought leaders, also known as key opinion leaders (KOLs), are under intense scrutiny. Industry ethicists and watchdogs alike have speculated on the objectivity of medical education presentations and other aspects of KOL involvement during the marketing of new drug therapies. However, the truth is that physician …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part One Read More »

Welcome to Our Blog!

Welcome to the Thought Leader Select Blog.  As we seek new ways to connect with our client companies and provide a more valuable experience with Thought Leader Select, our blog will serve as a venue for providing information about our products, services and the industries we serve, pharma and biotech.